A U.S. subsidiary of Tokyo-based Terumo Corporation, TMC is comprised of four divisions:
• Terumo Interventional Systems: a market leader in minimally invasive entry site management, lesion access and interventional technologies such as stents, balloons, sheaths and more.
• Terumo Medical Products: designs injection and infusion therapy devices that allow clinicians to deliver the very best day-to-day care to their patients in both the human and animal health markets.
• Terumo Pharmaceutical Solutions: crafts drug delivery devices that provide ease and comfort to both customers and their patients.
• Terumo Business Edge: a strategic business partner that provides healthcare systems with solutions that help optimize operations, reduce care variation, improve quality metrics, and prioritize investment strategies – resulting in improved patient outcomes, targeted cost savings, and maximized revenue.
Terumo was founded in 1921 to support fundamental public health in Japan. With our corporate mission of “Contributing to Society through Healthcare,” we have advanced along with healthcare to now operate in over 160 countries worldwide.
Overview
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 10, 2024 | Revolutionizing Bone Health with Osteoboost Wearable | Bone Health Technologies (BHT) secures $5M funding for Osteoboost, a game-changing solution for osteopenia and osteoporosis. Bone Health Technologies (BHT) is shaking up the bone health industry with its innovative Osteoboost wearable devic... |
| Jan 12, 2022 | Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A | SOMERSET, N.J., Jan. 12, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publication of updated guidelines from the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular... |
| Jul 14, 2021 | Terumo Introduces New AZUR™ Vascular Plug and PG Pro™ Peripheral Microcatheter Embolization System | SOMERSET, N.J., July 14, 2021 /PRNewswire/ -- Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diamete... |
| Jan 24, 2012 | The Nikkei: Sony Interested In Buying A 20%-30% Stake In Olympus | More news on the Sony–Olympus alliance that’s supposed to be announced soon: Japan’s biggest business daily The Nikkei is reporting today that big S is interested in purchasing a stake as large as “20%-30%” in its potential, scandal–hit par... |
| Bone Health Technologies Raises $5M for Osteopenia Care | What You Should Know: Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round from leading investmen... |
Reviews 0
FAQ about Kalila Medical (Terumo Medical)
When was Kalila Medical (Terumo Medical) founded?
Kalila Medical (Terumo Medical) was founded in 1921.
What has the press written about Kalila Medical (Terumo Medical)?
Parsers VC has collected 6 articles mentioning Kalila Medical (Terumo Medical), among them “Revolutionizing Bone Health with Osteoboost Wearable” (Mar 10, 2024) and “Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A” (Jan 12, 2022).
Is Kalila Medical (Terumo Medical) still active?
Yes, Kalila Medical (Terumo Medical) is active; its latest activity on Parsers VC dates from Oct 24, 2025.